Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact

Subscribe

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Actilyse 20 mg powder and solvent for solution for injection and infusion PA0775/011/002

Alteplase

Boehringer Ingelheim International GmbH

Marketed

Actilyse 50 mg powder and solvent for solution for injection and infusion PA0775/011/003

Alteplase

Boehringer Ingelheim International GmbH

Marketed

Actilyse Cathflo 2 mg powder for solution for injection and infusion PA0775/011/004

Alteplase

Boehringer Ingelheim International GmbH

Marketed

Actiprofen 200 mg tablets PA0678/061/002

Ibuprofen

Haleon Ireland Limited

Marketed

Actiq 200 micrograms compressed lozenge with integral oromucosal applicator PA1113/036/001

Fentanyl

Phoenix Labs Unlimited Company

Marketed

Actiq 400 micrograms compressed lozenge with integral oromucosal applicator PA1113/036/002

Fentanyl

Phoenix Labs Unlimited Company

Marketed

Actiq 400 micrograms compressed lozenge with integral oromucosal applicator PPA0465/407/002

Fentanyl

PCO Manufacturing Ltd.

—

Actiq 600 micrograms compressed lozenge with integral oromucosal applicator PA1113/036/003

Fentanyl

Phoenix Labs Unlimited Company

Marketed

Activelle 1 mg/0.5 mg film-coated tablets PA0218/052/001

Estradiol, Norethisterone acetate

Novo Nordisk A/S

Marketed

Actos EU/1/00/150/002

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actos EU/1/00/150/005

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actos EU/1/00/150/011

Pioglitazone

Takeda Pharma A/S

—

Actos 15 mg tablets EU/1/00/150/001

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actos 15 mg tablets EU/1/00/150/003

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actos 30 mg tablets EU/1/00/150/004

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actos 30 mg tablets EU/1/00/150/006

Pioglitazone

CHEPLAPHARM Arzneimittel GmbH

—

Actraphane EU/1/02/229/001-035

Insulin human

Novo Nordisk A/S

—

Actraphane 30 40 IU/ml Suspension for injection EU/1/02/229/036-037

Insulin human, Insulin human

Novo Nordisk A/S

—

Actrapid EU/1/02/230/001-015

Insulin human

Novo Nordisk A/S

—

Actrapid EU/1/02/230/016-017

Insulin human

Novo Nordisk A/S

—

Acular 0.5% w/v Eye Drops, solution PA1824/015/001

Ketorolac trometamol

Marketed

Acular 0.5% w/v Eye Drops, solution PPA1463/200/001

Ketorolac trometamol

IMED Healthcare Ltd.

Marketed

ACULAR 0.5% w/v Eye drops, solution PPA0465/287/001

Ketorolac trometamol

PCO Manufacturing Ltd.

—

Acvybra 60 mg solution for injection in pre-filled syringe EU/1/25/1983/001

Denosumab

Reddy Holding GmbH

—

Adaluzis 500mg Powder for concentrate for solution for infusion PA23450/003/001

Ceftobiprole medocaril sodium

Advanz Pharma Limited

Not marketed

ADASUVE 4.5 mg inhalation powder, pre-dispensed EU/1/13/823/001

Loxapine

Ferrer Internacional, S.A

—

ADASUVE 9.1 mg inhalation powder, pre-dispensed EU/1/13/823/002

Loxapine

Ferrer Internacional, S.A

—

ADCETRIS 50 mg powder for concentrate for solution for infusion EU/1/12/794/001

Brentuximab vedotin

Takeda Pharma A/S

—

Adcirca (previously Tadalafil Lilly) EU/1/08/476/001-004

Tadalafil

Eli Lilly Nederland B.V.

—

Adcirca 20 mg film-coated tablets EU/1/08/476/005-06

Tadalafil

Eli Lilly Nederland B.V.

—

Addiphos concentrate for solution for infusion PA2059/024/001

Potassium dihydrogen phosphate, Potassium hydroxide, Disodium phosphate dihydrate

Fresenius Kabi Deutschland GmbH

Marketed

Additrace N concentrate for solution for infusion PA2059/023/002

Chromic chloride hexahydrate, Copper chloride dihydrate, Ferric chloride hexahydrate, Manganese chloride tetrahydrate, Potassium iodide

Fresenius Kabi Deutschland GmbH

Marketed

Adempas 0.15 mg/mL granules for oral suspension EU/1/13/907/021

Riociguat

—

Adempas 0.5 mg film-coated tablets EU/1/13/907/001-003

Riociguat

—

Adempas 1 mg film-coated tablets EU/1/13/907/004-006

Riociguat

—

Adempas 1.5 mg film-coated tablets EU/1/13/907/007-009

Riociguat

—

Adempas 2 mg film-coated tablets EU/1/13/907/010-012

Riociguat

—

Adempas 2.5 mg film-coated tablets EU/1/13/907/013-015

Riociguat

—

Adenocor 3 mg/ml solution for injection PA0540/139/001

Adenosine

Sanofi-Aventis Ireland Limited T/A SANOFI

Marketed

Adenosine 3 mg/ml solution for injection in pre-filled syringe PA2059/004/001

Adenosine

Fresenius Kabi Deutschland GmbH

Marketed

Adenuric 80 mg film-coated tablets EU/1/08/447/001-002

Febuxostat

Menarini International Operations Luxembourg S.A.

—

Adenuric120 mg film-coated tablets EU/1/08/447/003-004

Febuxostat

Menarini International Operations Luxembourg S.A.

—

Adizem-SR 120 mg Prolonged Release Capsules PA1688/001/002

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

Adizem-SR 180 mg Prolonged Release Capsules PA1688/001/003

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

Adizem-SR 90 mg Prolonged Release Capsules PA1688/001/001

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

ADIZEM-XL 120mg prolonged release capsules PA1688/001/004

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

ADIZEM-XL 180mg prolonged release capsules PA1688/001/005

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

ADIZEM-XL 240 mg prolonged release capsules PA1688/001/006

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

ADIZEM-XL 300 mg prolonged release capsules PA1688/001/007

Diltiazem hydrochloride

Mundipharma Pharmaceuticals Limited

Marketed

Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU/1/09/578/001

Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1)

GlaxoSmithKline Biologicals S.A.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.